Linda Wagner-Weiner to Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
This is a "connection" page, showing publications Linda Wagner-Weiner has written about Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Connection Strength
0.767
-
Evaluating Renal Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome. Arthritis Rheumatol. 2025 May; 77(5):606-614.
Score: 0.224
-
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study. Arthritis Care Res (Hoboken). 2025 Apr; 77(4):504-512.
Score: 0.223
-
Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2022 09; 74(9):1550-1558.
Score: 0.187
-
Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey. Pediatr Rheumatol Online J. 2017 Aug 07; 15(1):61.
Score: 0.134